Myelodysplastic syndrome in the elderly
Myelodysplastic syndrome (MDS) is a group of malignant clonal diseases originating from pluripotent hematopoietic stem cells. The main characteristics are: ① abnormal development of blood cells, manifested as bone marrow ineffectiveness and morbid hematopoiesis; ② malignant clones retain a certain degree of differentiation potential and proliferate relatively slowly; ③ some eventually transform into acute leukemia, mainly acute myeloid leukemia (AML).
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Elderly population -
Related symptoms:
Fatigue Lymph node enlargement Splenomegaly Thrombocytopenia Dizziness -
Concurrent disease:
Related Drugs
Decitabine for injection
Indication: It is suitable for the first-time and retreatment of intermediate-2 and high-risk myelodysplastic syndrome (MDS) in the IPSS scoring system, including primary and secondary MDS, and all subtypes according to the FAB classification.
Manufacturer:
Zhengda Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Related Ingredients